Nasdaq GlobeNewswire

Enhesa Announces the Increase in Global Jurisdiction Coverage to 286 in 2018, and Celebrates Being Named to CIO Review's 20 Most Promising Compliance Technology Solution Providers

Del

Brussels, Belgium, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Enhesa, the leading global content provider focused on environmental, health and safety (EHS) regulatory compliance assurance support to industries worldwide, just announced the increase in global jurisdiction coverage for 2018 to reach up to 286.

Enhesa supports the Global EHS programs for many of the world's largest companies by offering a standardized, consistent suite of services enabling them to be aware of, and stay in compliance with, EHS laws wherever they operate. As a result, today, Enhesa offers off-the-shelf services in an impressive 286 jurisdictions.

New additions to the Enhesa geographic catalogue in 2018 (in English) include the following jurisdictions:

  • Argentina - Chaco
  • Argentina - Chubut
  • Azerbaijan
  • Burkina Faso
  • Canada - Northwest Territories
  • China - Guizhou
  • China - Hainan
  • China - Heilongjiang
  • Ecuador
  • German - Hanseatic City of Bremen
  • Germany - Mecklenburg - Western Pomerania
  • India Dadra -Nagar Haveli
  • India - Rajasthan
  • Macao
  • Malawi
  • Pakistan - Sindh
  • Slovenia
  • Switzerland - Solothurn
  • Switzerland - Vaud
  • Turkmenistan

Enhesa has also increased coverage by providing local language versions for the following jurisdictions:

  • Argentina - Chaco
  • Brazil - Alagoas
  • Brazil - Amazonas
  • Brazil - Maranhao
  • Brazil - Mato Grosso
  • Brazil - Parana
  • Brazil - Pernambuco
  • China - Fujian
  • China - Guizhou
  • China - Hainan
  • China - Heilongjiang
  • Guinea - National
  • Macao
  • Mali
  • Mexico - Chiapas
  • Mexico - Michoacan
  • Mexico - Quintana Roo
  • Mexico - Tlaxcala
  • Morocco
  • Paraguay
  • UAE - Abu Dhabi

Peter Hermans, Enhesa CEO further points out: "We are extremely proud of the truly global coverage we are able to offer our multinational clients. But our commitment to supporting our clients does not stop here. We will continue to partner with our current and future clients to expand our coverage as their presence around the world spreads, and provide them with the tools they need to manage EHS legal compliance at the corporate, regional, divisional and site levels."

In addition, Enhesa was selected, along with 19 other companies, to appear on CIO Review's list of "20 Most Promising Compliance Technology Solution Providers" for 2017. To help CCOs, CIOs, and CEOs find the right compliance technology provider for their enterprises, CIO Review's selection panel evaluated and shortlisted hundreds of compliance technology solution providers that are at the forefront of providing cutting-edge technology solutions.

Enhesa provides time-saving, simplified regulatory analysis translated by our in-house team of analysts - who represent approximately 45 nationalities around the world. This is why Enhesa is the leading solution to regulatory compliance forecasting and intelligence that will save you ample time and money.

To find out more about how Enhesa can help support your global EHS compliance program, please visit enhesa.com.


Company Description:

Enhesa helps global multinational companies be compliant with, and stay on top of, Environmental, Health & Safety (EHS) Regulations wherever they operate.

Enhesa's in-house team of multilingual regulatory analysts provide clear, concise and standardized content and insight on current and future EHS regulatory obligations in over 285 jurisdictions worldwide.

Enhesa's Compliance Intelligence and Regulatory Forecaster services can be provided as an automated data feed - integrated with the world's leading EHS software platforms.

Enhesa has offices in Brussels, Washington DC and Tokyo.

For more information, please visit enhesa.com or email info@enhesa.com

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/ce76d13c-c729-4af3-a523-e61b4b7cc362

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/1ecae2c0-6ed0-45a7-916c-f29b8c68eb53

Gloria Johnston
Enhesa
202-552-1090 ext. 203
gj@enhesa.com

Allison Gilmore
Enhesa
202-552-1090 ext. 242
agil@enhesa.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Enhesa via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Paper in Scientific Reports Highlights Ability of 4D Pharma’s MRx0004 to Protect Against Airway Inflammation in Severe Asthma14.8.2018 08:00Pressemelding

Data suggest that MRx0004 is a promising next-generation therapeutic for management of asthma LEEDS, United Kingdom, Aug. 14, 2018 (GLOBE NEWSWIRE) -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announces the publication of a paper demonstrating that MRx0004, a live biotherapeutic derived from the human gut microbiome, can protect against airway inflammation by reducing both neutrophilic and eosinophilic infiltration in a mouse model of severe asthma. The paper “Bifidobacterium breve MRx0004 protects against airway inflammation in a severe asthma model by suppressing both neutrophil and eosinophil lung infiltration” (Raftis et al.) is published in the Nature Publishing Group journal Scientific Reports . Asthma is a phenotypically heterogeneous disease. Between 5-10 % of asthma patients have a severe form of the disease which is refractory to steroid treatment and whose symptoms cannot be controlled despite the application o

Bombardier Continues African Market Penetration with Pre-Owned Q40013.8.2018 17:19Pressemelding

PassionAir becomes first Bombardier operator in Ghana with three Q400 aircraft MONTREAL, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Bombardier Commercial Aircraft announced today that the company successfully placed three pre-owned Q400 turboprops with PassionAir from the Republic of Ghana. The airline acquired the aircraft through a dry-lease with a third party. “Bombardier has sold about 3,500 new regional aircraft to date, and we continue to be very active on the used aircraft market.” said David Speirs, Vice President, Asset Management, Bombardier Commercial Aircraft. “Our recent momentum on the pre-owned aircraft market worldwide is a clear indication that our products are addressing a growing need for regional air transportation, especially in emerging markets.” “Our market penetration in Africa continues to intensify, and we are pleased to welcome Passion Air as the first commercial airline operating a Bombardier regional aircraft in the Republic of Ghana,” said Jean-Paul Boutibou, Vice

SEMAFO: Armed Incident in Est Region13.8.2018 17:09Pressemelding

MONTREAL, Aug. 13, 2018 (GLOBE NEWSWIRE) -- SEMAFO Inc. (TSX, OMX: SMF) regrets to report that an armed incident occurred between the town of Fada and the Boungou Mine site in the Est region of Burkina Faso. As a result, five gendarmes and one sub-contractor employee lost their lives. Operations at the Boungou Mine were not affected. As a precautionary measure, we will be increasing our security measures and continue to closely monitor the situation with our partners to protect the safety of SEMAFO employees and our operations. The Corporation would like to express its deepest sympathy to families of the victims. About SEMAFO SEMAFO is a Canadian-based mining company with gold production and exploration activities in West Africa. The Corporation operates the Mana Mine in Burkina Faso, which includes the high-grade satellite deposit of Siou, and is targeting commercial production at the Boungou Mine in the third quarter of 2018. SEMAFO is committed to evolve in a conscientious manner to

Checkpoint Therapeutics Announces Clinical Data on EGFR Inhibitor CK-101 Selected for Late-Breaking Oral Presentation at IASLC 19th World Conference on Lung Cancer13.8.2018 14:00Pressemelding

NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that preliminary safety and efficacy data from a Phase 1/2 clinical trial of CK-101 (also known as RX518), a third-generation epidermal growth factor receptor (“EGFR”) tyrosine kinase inhibitor (“TKI”) being evaluated in advanced non-small cell lung cancer, has been selected for a late-breaking oral presentation at the International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer, to be held September 23-26, 2018, in Toronto. "We are thrilled to announce that preliminary data from the Phase 1/2 trial of our novel third-generation EGFR inhibitor has been selected for a late-breaking oral presentation at the World Conference on Lung Cancer. This marks the

Mash Group Plc reports interim unaudited financials, H1 2018 ended 30th June 201813.8.2018 08:00Pressemelding

Mash Group reports record H1/18 revenue, up 99% from H1/17. With H1/18 lending volumes surpassing full year 2017 and a strong EBIT of EUR 5.5 million achieved, Mash Group is extremely well positioned to continue executing on its growth plan, comments CEO Hickson . Mash continued to grow rapidly in all markets during the second quarter, achieving record lending volumes and maintaining strong momentum. Strategic Highlights Mash increases the size of its structured financing facility with funds managed by affiliates of Fortress Investment Group LLC (NYSE:FIG), from EUR 120 million to EUR 200 million. Mash was recognized as one of the Fintech50, Europe’s leading list of FinTech companies. AI Global Media, award CEO Hickson ‘Most Influential FinTech CEO of the year 2018’. Operational Highlights Mash continued to grow rapidly in all markets during the second quarter, achieving a record Q2 2018 in terms of lending volumes (+27%) and revenues (+36%) compared to Q1 2018. Registered merchants fo

ATPCO Awarded Patent for Cacheless Airline Ticket Pricing Model13.8.2018 06:00Pressemelding

Establishes Technology Foundational to Next-Gen Airline Revenue Management Tools DULLES, Va., Aug. 13, 2018 (GLOBE NEWSWIRE) -- ATPCO today announced that it has been awarded Patent #10,032,195 by the United States Patent and Trademark Office to cover new technology, developed by its data scientists and technical architects, that enables construction of airline ticket prices using graph database and “functional programming” techniques. This technology permits a unique approach to calculating airfare prices that was not previously available. Airline ticket prices are built using diverse individual data components: fares, flight schedules, taxes, and various legal and governance structures. An airline also sets business restrictions, known as rules, to determine under what circumstances a fare may be offered, such as requiring a Saturday-night stay or during pre-determined promotional sale dates. All these elements must be referenced and incorporated into the final price of an airline ti

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom